MD3477F1 - Method of treating the chronic viral hepatitis C - Google Patents
Method of treating the chronic viral hepatitis C Download PDFInfo
- Publication number
- MD3477F1 MD3477F1 MDA20070074A MD20070074A MD3477F1 MD 3477 F1 MD3477 F1 MD 3477F1 MD A20070074 A MDA20070074 A MD A20070074A MD 20070074 A MD20070074 A MD 20070074A MD 3477 F1 MD3477 F1 MD 3477F1
- Authority
- MD
- Moldova
- Prior art keywords
- viral hepatitis
- chronic viral
- treating
- hepatoprotective
- treatment
- Prior art date
Links
- 208000005176 Hepatitis C Diseases 0.000 title abstract 2
- 230000001684 chronic effect Effects 0.000 title abstract 2
- 208000010710 hepatitis C virus infection Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 230000002443 hepatoprotective effect Effects 0.000 abstract 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000000812 cholinergic antagonist Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 230000002048 spasmolytic effect Effects 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Inventia se refera la medicina, si anume la hepatologie si este destinata pentru tratamentul hepatitei virale cronice C. Metoda, conform inventiei, consta in aceea ca se administreaza 300 … 400 ml solutie de NaCl 0,9% ozonizata, care contine 4 … 5 mg/l ozon, intravenos in picaturi peste o zi cate 10…12 sedinte la o serie si concomitent zilnic se administreaza spasmolitice, aminoacizi si hepatoprotectori in doza zilnica obisnuita. Dupa terminarea seriei in decurs de 5 … 6 luni se administreaza un hepatoprotector. Totodata, tratamentul se efectueaza cel putin trei ani.The invention relates to medicine, namely to hepatology and is intended for the treatment of chronic viral hepatitis C. The method according to the invention consists in administering 300 ... 400 ml 0.9% ozonized NaCl solution, containing 4 ... 5 mg / l ozone, intravenously in drops over a day for 10 to 12 sessions at a time and at the same time daily is given spasmolytic, amino acids and hepatoprotective in the usual daily dose. After the completion of the series within 5 ... 6 months, a hepatoprotective is given. At the same time, the treatment is performed at least three years.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20070074A MD3477G2 (en) | 2007-03-21 | 2007-03-21 | Method of treating the chronic viral hepatitis C |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20070074A MD3477G2 (en) | 2007-03-21 | 2007-03-21 | Method of treating the chronic viral hepatitis C |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD3477F1 true MD3477F1 (en) | 2008-01-31 |
| MD3477G2 MD3477G2 (en) | 2008-08-31 |
Family
ID=39047744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20070074A MD3477G2 (en) | 2007-03-21 | 2007-03-21 | Method of treating the chronic viral hepatitis C |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD3477G2 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
| US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
| US8809265B2 (en) | 2011-10-21 | 2014-08-19 | Abbvie Inc. | Methods for treating HCV |
| US8853176B2 (en) | 2011-10-21 | 2014-10-07 | Abbvie Inc. | Methods for treating HCV |
| WO2017189978A1 (en) | 2016-04-28 | 2017-11-02 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD596Z (en) * | 2012-10-09 | 2013-09-30 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Method for treating chronic viral hepatitis C in children |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD2327G2 (en) * | 2003-07-11 | 2004-07-31 | Андрей ПЫРГАРЬ | Method of treatment of parodontium affections |
| MD2375G2 (en) * | 2003-07-29 | 2004-08-31 | Константин ЦЫБЫРНЭ | Method of portal gastropathy treatment in hepatic cirrhosis |
| MD2354G2 (en) * | 2003-07-29 | 2004-07-31 | Борис ПЫРГАРЬ | Method of treatment of the hepatic encephalopathy |
| UA5435U (en) * | 2004-06-03 | 2005-03-15 | Богдан Григорович Бондарчук | Ozone retroperitoneum technique for treating severe acute destructive pancreatitis with high risk of infection and infectious pancreonecrosis |
| UA11883U (en) * | 2005-07-04 | 2006-01-16 | Viktor Mykolaiovych Mahalias | Method for sanitization of peritoneal cavity in biliary peritonitis |
-
2007
- 2007-03-21 MD MDA20070074A patent/MD3477G2/en not_active IP Right Cessation
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
| US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
| US8680106B2 (en) | 2011-10-21 | 2014-03-25 | AbbVic Inc. | Methods for treating HCV |
| US8685984B2 (en) | 2011-10-21 | 2014-04-01 | Abbvie Inc. | Methods for treating HCV |
| US8809265B2 (en) | 2011-10-21 | 2014-08-19 | Abbvie Inc. | Methods for treating HCV |
| US8853176B2 (en) | 2011-10-21 | 2014-10-07 | Abbvie Inc. | Methods for treating HCV |
| US8969357B2 (en) | 2011-10-21 | 2015-03-03 | Abbvie Inc. | Methods for treating HCV |
| US8993578B2 (en) | 2011-10-21 | 2015-03-31 | Abbvie Inc. | Methods for treating HCV |
| US9452194B2 (en) | 2011-10-21 | 2016-09-27 | Abbvie Inc. | Methods for treating HCV |
| WO2017189978A1 (en) | 2016-04-28 | 2017-11-02 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
| US11192914B2 (en) | 2016-04-28 | 2021-12-07 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
Also Published As
| Publication number | Publication date |
|---|---|
| MD3477G2 (en) | 2008-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MD3477F1 (en) | Method of treating the chronic viral hepatitis C | |
| JP2009530385A5 (en) | Administration of ketamine for the treatment of depression | |
| CO6241170A2 (en) | ADMINISTRATION OF ANTISENTIDE OLIGONUCLEOTIDES COMPLEMENTARY TO HUMAN APOLIPOPROTEIN B | |
| CY1116215T1 (en) | Combination therapy for the therapeutic treatment of Protein Deficiency Disorders | |
| HRP20171939T1 (en) | ANTIBODY FORMULATION AND THERAPY REGIMES | |
| JP2008044951A5 (en) | ||
| EA200802012A1 (en) | PHARMACEUTICAL PREPARATIONS IN THE FORM OF SOLUTION FOR DOSING INHALERS UNDER PRESSURE | |
| IL196425A0 (en) | Pharmaceutical compositions containing ibuprofen and famotidine | |
| KR20140025314A (en) | A combination composition | |
| ECSP088348A (en) | IRON SUPPLEMENT COMPOSITIONS WITH IMPROVED TOLERANCE | |
| RU2009118962A (en) | APPLICATION OF IL-1 ANTAGONISTS FOR TREATMENT OF GHIT AND PSEUDOGRAPHY | |
| HUP0301828A2 (en) | Use of apomorphine for the production of pharmaceutical compositions for treating sexual dysfunction with apomorphine at specified plasma concentration levels | |
| RU2011111792A (en) | APPLICATION OF PARACETAMOL AND IBUPROFEN IN TREATMENT | |
| ATE499933T1 (en) | USE OF BETAIN TO TREAT INTERMITTENS CLAUDICATIO | |
| RU2003127718A (en) | APPLICATION OF FLUMAZENIL IN THE PRODUCTION OF A MEDICINE FOR TREATING COCAIN DEPENDENCE | |
| JP2019529569A5 (en) | ||
| RU2007104774A (en) | COMBINATION OF ANTI-HIV REVERSE TRANSCRIPTASE AND PROTEASES INHIBITORS | |
| EA200800397A1 (en) | TIZANIDINE COMPOSITIONS AND TREATMENT METHODS USING COMPOSITIONS | |
| WO2009019307A3 (en) | Oral calcitonin compositions and applications thereof | |
| CL2020002803A1 (en) | R-fadrozole for use in the treatment of aldosteronism | |
| GT200600263A (en) | DOSAGE REGIME FOR PRASUGREL | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| UA93365C2 (en) | Injectable preparations of diclofenic and its pharmaceutically acceptable salts, and processes for the preparation thereof | |
| ATE446309T1 (en) | CAPILLARY RESISTANCE IMPROVEMENT PEPTIDE SUBSTANCE, PHARMACEUTICAL COMPOSITION BASED THEREOF AND METHOD FOR USE THEREOF | |
| US7955623B2 (en) | Pharmaceutical preparations for treating inflammatory diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |